Log In
Print
BCIQ
Print
Print this Print this
 

Lunesta, Lunivia, eszopiclone

Also known as: formerly Estorra

  Manage Alerts
Collapse Summary General Information
Company Sumitomo Dainippon Pharma Co. Ltd.
DescriptionNon-benzodiazepine cyclopyrrolone GABA receptor modulator
Molecular Target GABA receptor
Mechanism of ActionGABA receptor modulator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationInsomnia
Indication DetailsTreat chronic insomnia; Treat insomnia; Treat insomnia in patients with co-existing generalized anxiety disorder (GAD); Treat insomnia in patients with co-existing rheumatoid arthritis (RA); Treat insomnia in perimenopausal and menopausal women; Treat insomnia with co-existing major depressive disorder (MDD); Treat pediatric insomnia; Treat primary insomnia; Treat primary insomnia in elderly patients; Treat transient and chronic insomnia
Regulatory Designation
Partner Eisai Co. Ltd.; GlaxoSmithKline plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$2,600.0M

$2,600.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today